XML 94 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Marketable Securities
12 Months Ended
Dec. 29, 2013
Marketable Securities [Abstract]  
Marketable Securities
Marketable Securities
Our marketable debt and equity securities consisted of the following:
(In thousands)
 
December 29,
2013
 
December 30,
2012
Short-term marketable securities
 
 
 
 
Marketable debt securities
 
 
 
 
U.S Treasury securities
 
$
143,510

 
$
124,831

Corporate debt securities
 
78,991

 

U.S. agency securities
 
31,518

 

Municipal securities
 
48,035

 

Certificates of deposit
 
31,949

 

Commercial paper
 
30,877

 
9,989

Total short-term marketable securities
 
$
364,880

 
$
134,820

Long-term marketable securities
 
 
 
 
Marketable debt securities
 
 
 
 
Corporate debt securities
 
$
98,979

 
$

U.S. agency securities
 
73,697

 

Municipal securities
 
3,479

 

Total
 
176,155

 

Marketable equity security
 
 
 
 
Available-for-sale security
 

 
4,444

Total long-term marketable securities
 
$
176,155

 
$
4,444


Marketable debt securities
As of December 29, 2013, our marketable securities had remaining maturities of 1 month to 36 months.
Marketable equity security
Our investment in the common stock of Brightcove, Inc. was accounted for as available-for-sale and stated at fair value. Changes in the fair value of our available-for-sale security were recognized as unrealized gains or losses within “Long-term marketable securities” and “Accumulated other comprehensive loss, net of income taxes” in our Condensed Consolidated Balance Sheets and “Unrealized gain/(loss) on available-for-sale security” in our Condensed Consolidated Statements of Comprehensive Income/(Loss).
During the fourth quarter of 2013, we sold our remaining investment in the common stock of Brightcove, Inc. We received cash proceeds of $5.5 million and recognized a gain of $1.1 million, ($0.7 million, net of tax). Upon sale, net realized gains were transferred from accumulated other comprehensive income into the Condensed Consolidated Statement of Income.
See Note 10 for additional information regarding the fair value of our marketable securities.